# FDA recall Z-2660-2026

> **Bard Access Systems, Inc.** · Class II · device recall initiated 2026-05-21.

## Product

5605150	Power-Trialysis Short-Term Straight Dialysis Catheter 13 Fr Triple-Lumen  UDI-DI Code: 00801741086953    5605240	Power-Trialysis Short-Term Straight Dialysis Catheter 13 Fr Triple-Lumen  UDI-DI Code: 00801741086977    5605300	Power-Trialysis Short-Term Straight Dialysis Catheter 13 Fr Triple-Lumen  UDI-DI Code: 00801741086984    5615120	Power-Trialysis Short-Term Curved Extension Dialysis Catheter 13 Fr Triple-Lumen  UDI-DI Code: 00801741075087    5615200	Power-Trialysis Short-Term Curved Extension Dialysis Catheter 13 Fr Triple-Lumen  UDI-DI Code: 00801741075100    5615200	Power-Trialysis Short-Term Curved Extension Dialysis Catheter 13 Fr Triple-Lumen  UDI-DI Code: 00801741075100    5615200	Power-Trialysis Short-Term Curved Extension Dialysis Catheter 13 Fr Triple-Lumen  UDI-DI Code: 00801741075100    5655120	Power-Trialysis Short-Term Alphacurve Dialysis Catheter 13 Fr Triple-Lumen  UDI-DI Code: 00801741066054      The Power-Trialysis" Short-Term Dialysis Catheter, with a third internal lumen for intravenous therapy, power injection of contrast media, and central venous pressure monitoring, is indicated for use in attaining short-term (less than 30 days) vascular access for hemodialysis, hemoperfusion, and apheresis treatments. The catheter is intended to be inserted in the jugular, femoral, or subclavian vein as required. The maximum recommended infusion rate is 5 mL/sec for power injection of contrast media.

## Reason for recall

Due to lidocaine ampoules being manufactured under deficient manufacturing practices by manufacturer, lidocaine ampoules are currently being recalled by supplier.

## Distribution

Worldwide U.S. Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, WA, WI, WV, and WY. The country of Belgium.

## Key facts

- **Recall number:** Z-2660-2026
- **Recalling firm:** Bard Access Systems, Inc.
- **Classification:** Class II
- **Product type:** device
- **Status:** Ongoing
- **Initiation date:** 2026-05-21
- **Report date:** 2026-07-08

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Salt Lake City, UT, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-2660-2026

## Citation

> MORVS. FDA recall Z-2660-2026. Retrieved 2026-10-22 from https://api.morvs.ai/recall/Z-2660-2026. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*